Sign in

CIK 0001615219

  • Non-accelerated filer
  • Smaller reporting company

Decoy Therapeutics Inc.

Sign in to watch
Ticker
DCOY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465087339
Phone
+1 346-772-0346
Business address
2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
Former names
Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. S-3 Offering Registration Statement
  3. 10-Q Report Quarterly Report
  4. EFFECT Other Notice of Effectiveness
  5. 424B3 Offering Prospectus
  6. S-1 Offering Registration Statement
  7. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  8. 8-K Event Shareholder vote results
  9. 4 Grant or award Director acquired 2,000 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 33,455 shares (grant or award)
  11. 4 Grant or award Chief Business Officer acquired 3,900 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 9,682 shares (grant or award)
  13. 4 Grant or award Chief Scientific Officer acquired 4,216 shares (grant or award)
  14. 4 Grant or award Director acquired 3,000 shares (grant or award)
  15. 4 Grant or award Director acquired 2,000 shares (grant or award)
  16. 4 Grant or award Director acquired 2,000 shares (grant or award)
  17. 4 Grant or award Director acquired 3,000 shares (grant or award)
  18. 4 Grant or award Director acquired 2,000 shares (grant or award)
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. 10-Q Report Quarterly Report

Page 1 of 38 · 746 filings